Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

Kathy Ingebrand was diagnosed with Alzheimer's at 59 years old. "This patient is receiving a treatment, which is designed to clear a protein called amyloid from the brain, which is accumulating in ...

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.

LAFAYETTE, Ind. — Time with a loved one diagnosed with Alzheimer's disease is precious, and a new first-of-its-kind treatment now offered at IU Health Arnett aims to prolong that time.

On the other hand, sleep problems like insomnia and sleep apnea can lead to serious health issues and even increase the risk ...

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...

China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen's Leqembi received approval in January ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ...